Investor insights
Sectors invested in
Funding rounds participated in
$33M sweet spot round size
Most of their 5 investments are in rounds between $9.1M and $102M
Basic info
Industry
Sectors
Date founded
1989
Investments made
Arbor Biotechnologies raised $215M on November 9, 2021
Investors: TCG X, Tao Capital Partners, Surveyor Capital, Tekla Capital Management, T. Rowe Price, Section 32, Temasek, Ridgeback Capital Management LLC, Woodline Partners LP and Vertex Pharmaceuticals
Kymera Therapeutics raised $102M on March 12, 2020
Investors: Solasta Ventures, Bessemer Venture Partners, Wellington Management, Redmile Group and Vertex Pharmaceuticals
Undisclosed raised $9.1M on December 9, 2018
Investors: Invesco Perpetual, Oxford Sciences Innovation, Foresite Capital, Woodford Investment Management, IP Group plc, F-Prime Capital Partners and Vertex Pharmaceuticals
Undisclosed raised $33M on August 30, 2018
Investors: Invesco Perpetual, Oxford Sciences Innovation, Woodford Investment Management, IP Group plc, Lansdowne Partners and Vertex Pharmaceuticals
CRISPR Therapeutics raised $29M on April 30, 2015
Investors: S.R. One Ltd, Celgene, Abingworth, Versant Ventures and Vertex Pharmaceuticals
Funding rounds raised
Total raised
$443M
from 5 investors over 5 rounds
Vertex Pharmaceuticals raised $443M on December 3, 2009
Investors: Bank of America Merrill Lynch
Vertex Pharmaceuticals raised $35M on September 30, 2009
Investors: Janssen Belgium
Vertex Pharmaceuticals raised undisclosed on July 17, 1989
Investors: J.H. Whitney Capital Partners, LLC, Norwest Venture Partners and Greylock Partners